Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients

British Journal of Haematology

Volumn 174, Issue 1, 2016, Pages 148-152

  Nielsen, Louise ^a,b   Canouï Poitrine, Florence ^a,b   Jais, Jean Philippe ^c,d   Dahmane, Djamal ^a   Bartolucci, Pablo ^a,e   Bentaarit, Bouteina ^a   Gellen Dautremer, Justine ^a   Remy, Philippe ^a,b   Kofman, Tomek ^a,b   Matignon, Marie ^a,b   Suberbielle, Caroline ^f   Jacquelinet, Christian ^g,h   Wagner Ballon, Orianne ^a,b   Sahali, Dil ^a,b   Lang, Philippe ^a,b   Damy, Thibaud ^a,b   Galactéros, Frédéric ^a,e   Grimbert, Philippe ^a,b   Habibi, Anoosha ^a,e   Audard, Vincent ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e INSERM U955   (France)

^f SAINT LOUIS HOSPITAL   (France)

^g Direction Générale Médicale et Scientifique   (France)

^h CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

Author keywords

dialysis; kidney; sickle cell disease; survival; vaso occlusive crises

Indexed keywords

DEFERASIROX; DEFEROXAMINE; HEMOGLOBIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; MORBIDITY; MORTALITY RATE; PHLEBOTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SICKLE CELL ANEMIA; SURVIVAL RATE; TREATMENT DURATION;

EID: 84976482998     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14040     Document Type: Article

References (12)

1. Abbott, K.C., Hypolite, I.O. & Agodoa, L.Y. (2002) Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clinical Nephrology, 58, 9–15.
2. De Franceschi, L., Cappellini, M.D. & Olivieri, O. (2011) Thrombosis and sickle cell disease. Seminars in Thrombosis and Hemostasis, 37, 226–236.
3. Falk, R.J., Scheinman, J., Phillips, G., Orringer, E., Johnson, A. & Jennette, J.C. (1992) Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. New England Journal of Medicine, 326, 910–915.
4. Huang, E., Parke, C., Mehrnia, A., Kamgar, M., Pham, P.T., Danovitch, G. & Bunnapradist, S. (2013) Improved survival among sickle cell kidney transplant recipients in the recent era. Nephrology Dialysis Transplantation, 28, 1039–1046.
5. Lok, C.E. & Foley, R. (2013) Vascular access morbidity and mortality: trends of the last decade. Clinical Journal of the American Society of Nephrology, 8, 1213–1219.
6. Maigne, G., Ferlicot, S., Galacteros, F., Belenfant, X., Ulinski, T., Niaudet, P., Ronco, P., Godeau, B., Durrbach, A., Sahali, S., Lang, P., Lambotte, O. & Audard, V. (2010) Glomerular lesions in patients with sickle cell disease. Medicine, 89, 18–27.
7. McClellan, A.C., Luthi, J.-C., Lynch, J.R., Soucie, J.M., Kulkarni, R., Guash, A., Huff, E.D., Gilbertson, D., McClellan, W.M. & DeBaun, M.R. (2012) High one year mortality in adults with sickle cell disease and end-stage renal disease. British Journal of Haematology, 159, 360–367.
8. Ojo, A.O., Govaerts, T.C., Schmouder, R.L., Leichtman, A.B., Leavey, S.F., Wolfe, R.A., Held, P.J., Port, F.K. & Agodoa, L.Y. (1999) Renal transplantation in end-stage sickle cell nephropathy. Transplantation, 67, 291–295.
9. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klug, P.P. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. New England Journal of Medicine, 330, 1639–1644.
10. Saraf, S.L., Zhang, X., Kanias, T., Lash, J.P., Molokie, R.E., Oza, B., Lai, C., Rowe, J.H., Gowhari, M., Hassan, J., DeSimonne, J., Machado, R.F., Gladwin, M.T., Little, J.A. & Gordeuk, V.R. (2014) Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia. British Journal of Haematology, 164, 729–739.
11. Sharpe, C.C. & Thein, S.L. (2014) How I treat renal complications in sickle cell disease. Blood, 123, 3720–3726.
12. Steinberg, M.H. (1991) Erythropoietin for anemia of renal failure in sickle cell disease. New England Journal of Medicine, 324, 1369–1370.